Skip to main content
Log in

The impact of antibiotic-impregnated catheters on shunt infection in children and neonates

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Introduction

Infection remains a significant problem with cerebrospinal fluid (CSF) diversion procedures. Antibiotic-impregnated shunt catheters (AIS) have been introduced to prevent infection, mainly in the early post-operative period when most infections occur. We evaluate the impact on infection rates in children following the introduction of catheters impregnated with rifampicin and clindamycin.

Materials and methods

The study was a retrospective analysis of all paediatric shunt procedures undertaken after the introduction of AIS systems in 2003. All procedures where a complete AIS system was implanted were included. For the purpose of analysis, shunt procedures were classified as de novo (group 1), clean revision (group 2) and following external ventricular drainage with either sterile CSF (group 3) or infected CSF (group 4). Results were compared to a historical cohort of shunt procedures undertaken before the introduction of AIS catheters.

Results

A total of 214 AIS were implanted in 150 children between October 2003 and December 2006. There were 4 infections in group 1 (8.5%), 6 infections in group 2 (5.3%) and 11 infections in groups 3 and 4 (20%). The historical control group comprised 77 shunts in 65 children. The infection rate in neonatal de novo shunts reduced from 27 to 10.4% following the introduction of AIS catheters.

Conclusions

AIS catheters can reduce the number of shunt infections seen in clinical practice in certain subgroups. This has had a significant impact on the neonatal hydrocephalic population. The high risk of shunt infection after a period of external ventricular drainage raises the issue of emergence of bacterial resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56–61

    Article  PubMed  Google Scholar 

  2. Bayston R (1989) Hydrocephalus shunt infections. Chapman and Hall, London

    Google Scholar 

  3. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605–609

    PubMed  CAS  Google Scholar 

  4. Bayston R, Lambert E (1997) Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247–251

    PubMed  CAS  Google Scholar 

  5. Bayston R, Ashraf W, Bhundia C (2004) Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778–782

    Article  PubMed  CAS  Google Scholar 

  6. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1–7

    Article  CAS  Google Scholar 

  7. Choux M, Genitori L, Lang D, Lena G (1992) Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875–880

    PubMed  CAS  Google Scholar 

  8. Drake JM, Sainte-Rose C (1995) The Shunt book. Blackwell Science, Cambridge, Mass

    Google Scholar 

  9. Enger PO, Svendsen F, Wester K (2003) CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien) 145:243–248 discussion 248

    Article  CAS  Google Scholar 

  10. Fan-Havard P, Nahata MC (1987) Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866–880

    PubMed  CAS  Google Scholar 

  11. Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831–839

    PubMed  Google Scholar 

  12. Kan P, Kestle J (2007) Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23:773–777

    Article  PubMed  Google Scholar 

  13. Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195–201

    PubMed  CAS  Google Scholar 

  14. Pattavilakom A, Kotasnas D, Korman TM, Xenos C, Danks A (2006) Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 58:930–935 discussion 930–935

    Article  PubMed  Google Scholar 

  15. Pople IK, Bayston R, Hayward RD (1992) Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29–36

    PubMed  CAS  Google Scholar 

  16. Ronan A, Hogg GG, Klug GL (1995) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 14:782–786

    PubMed  CAS  Google Scholar 

  17. Schiff SJ, Oakes WJ (1989) Delayed cerebrospinal-fluid shunt infection in children. Pediatr Neurosci 15:131–135

    Article  PubMed  CAS  Google Scholar 

  18. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131–136

    PubMed  Google Scholar 

  19. Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI (2007) Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23:867–871

    Article  PubMed  Google Scholar 

  20. Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J (1988) Origin of organisms infecting ventricular shunts. Neurosurgery 22:868–872

    Article  PubMed  CAS  Google Scholar 

  21. Vanaclocha V, Saiz-Sapena N, Leiva J (1996) Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien) 138:829–834

    Article  CAS  Google Scholar 

  22. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014–1021

    PubMed  CAS  Google Scholar 

  23. Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, Chuang YC, Liliang PC, Su TM, Rau CS, Tsai YD, Cheng BC, Hung PL, Chang CJ, Lu CH (2004) Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis 57:44–48

    PubMed  Google Scholar 

  24. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, Hamilton AJ (2003) Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 98:725–730

    Article  PubMed  Google Scholar 

Download references

Disclosure

The authors confirm that no financial support has been received for the inception or preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caroline Hayhurst.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayhurst, C., Cooke, R., Williams, D. et al. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 24, 557–562 (2008). https://doi.org/10.1007/s00381-007-0521-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-007-0521-4

Keywords

Navigation